Literature DB >> 8876251

Correction of hypertension by normalization of endothelial levels of fibroblast growth factor and nitric oxide synthase in spontaneously hypertensive rats.

P Cuevas1, M García-Calvo, F Carceller, D Reimers, M Zazo, B Cuevas, I Muñoz-Willery, V Martínez-Coso, S Lamas, G Giménez-Gallego.   

Abstract

Acidic and basic fibroblast growth factors (FGFs) share a wide range of diverse biological activities. To date, low levels of FGF have not been correlated with a pathophysiologic state. We report that blood vessels of spontaneously hypertensive rats are shown to be associated with a marked decrement in endothelial basic FGF content. This decrement correlates both with hypertension and with a decrease in the endothelial content of nitric oxide synthase. Restoration of FGF to physiological levels in the vascular wall, either by systemic administration or by in vivo gene transfer, significantly augmented the number of endothelial cells with positive immunostaining for nitric oxide synthase, corrected hypertension, and ameliorated endothelial-dependent responses to vasoconstrictors. These results suggest an important role for FGFs in blood pressure homeostasis and open new avenues for the understanding of the etiology and treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8876251      PMCID: PMC38172          DOI: 10.1073/pnas.93.21.11996

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Development of a strain of spontaneously hypertensive rats.

Authors:  K OKAMOTO; K AOKI
Journal:  Jpn Circ J       Date:  1963-03

2.  Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat.

Authors:  T K Rosengart; J P Kuperschmid; T Maciag; R E Clark
Journal:  Circ Res       Date:  1989-02       Impact factor: 17.367

3.  Validity of an indirect tail-cuff method for determining systolic arterial pressure in unanesthetized normotensive and spontaneously hypertensive rats.

Authors:  J M Pfeffer; M A Pfeffer; E D Frohlich
Journal:  J Lab Clin Med       Date:  1971-12

4.  A specific deficiency in paraventricular vasopressin and oxytocin in the spontaneously hypertensive rat.

Authors:  M Morris; M Keller
Journal:  Brain Res       Date:  1982-10-07       Impact factor: 3.252

5.  Regional changes in the activities of aminergic biosynthetic enzymes in the brains of hypertensive rats.

Authors:  A Nagaoka; W Lovenberg
Journal:  Eur J Pharmacol       Date:  1977-06-15       Impact factor: 4.432

6.  Reduced content of vasopressin in the brain of spontaneously hypertensive as compared to normotensive rats.

Authors:  R E Lang; W Rascher; T Unger; D Ganten
Journal:  Neurosci Lett       Date:  1981-05-06       Impact factor: 3.046

7.  Central neural peptides and catecholamines in spontaneous and DOCA/salt hypertension.

Authors:  M Morris; J A Wren; D K Sundberg
Journal:  Peptides       Date:  1981       Impact factor: 3.750

8.  Basic fibroblast growth factor increases nitric oxide synthase production in bovine endothelial cells.

Authors:  S K Kostyk; S Kourembanas; E L Wheeler; D Medeiros; L P McQuillan; P A D'Amore; S J Braunhut
Journal:  Am J Physiol       Date:  1995-11

9.  Role of endothelium-derived nitric oxide in the regulation of blood pressure.

Authors:  D D Rees; R M Palmer; S Moncada
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.

Authors:  T F Lüscher; P M Vanhoutte
Journal:  Hypertension       Date:  1986-04       Impact factor: 10.190

View more
  13 in total

Review 1.  Nitrones as therapeutics.

Authors:  Robert A Floyd; Richard D Kopke; Chul-Hee Choi; Steven B Foster; Sabrina Doblas; Rheal A Towner
Journal:  Free Radic Biol Med       Date:  2008-08-29       Impact factor: 7.376

2.  Reversible suppression of nitric oxide system in essential hypertension.

Authors:  M Chandra; D R Maurya; S Kumar; H Basara; A Ghatak; B L Tekwani; G Kaur; M K Misra
Journal:  Indian J Clin Biochem       Date:  2003-07

3.  Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors.

Authors:  Israel S Fernández; Pedro Cuevas; Javier Angulo; Pilar López-Navajas; Angeles Canales-Mayordomo; Rocío González-Corrochano; Rosa M Lozano; Serafín Valverde; Jesús Jiménez-Barbero; Antonio Romero; Guillermo Giménez-Gallego
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

Review 4.  Cardiovascular gene delivery: The good road is awaiting.

Authors:  L P Brewster; E M Brey; H P Greisler
Journal:  Adv Drug Deliv Rev       Date:  2006-07-07       Impact factor: 15.470

5.  Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice.

Authors:  R Dono; G Texido; R Dussel; H Ehmke; R Zeller
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

6.  Circulating vascular endothelial growth factor and nitric oxide in patients with liver cirrhosis: A possible association with liver function impairment.

Authors:  Mohamed Ahmed Abdelmoaty; Ahmed Mohamed Bogdady; Mervat Mohamed Attia; Nayel Abdelhamed Zaky
Journal:  Indian J Clin Biochem       Date:  2009-12-30

7.  Blood Pressure Control by a Secreted FGFBP1 (Fibroblast Growth Factor-Binding Protein).

Authors:  Elena Tassi; En Yin Lai; Lingli Li; Glenn Solis; Yifan Chen; William E Kietzman; Patricio E Ray; Anna T Riegel; William J Welch; Christopher S Wilcox; Anton Wellstein
Journal:  Hypertension       Date:  2017-11-20       Impact factor: 10.190

Review 8.  The FGF family: biology, pathophysiology and therapy.

Authors:  Andrew Beenken; Moosa Mohammadi
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

Review 9.  Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia.

Authors:  Marc Ruel; Jianming Song; Frank W Sellke
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

10.  Acute Kidney Injury Sensitizes the Brain Vasculature to Ang II (Angiotensin II) Constriction via FGFBP1 (Fibroblast Growth Factor Binding Protein 1).

Authors:  Liang Zhao; Xiaoyun Cao; Lingli Li; Xiaohua Wang; Qin Wang; Shan Jiang; Chun Tang; Suhan Zhou; Nan Xu; Yu Cui; Weipeng Hu; Lingyan Fei; Zhihua Zheng; Limeng Chen; Marcel O Schmidt; Qichun Wei; Jingwei Zhao; Robert Labes; Andreas Patzak; Christopher S Wilcox; Xiaodong Fu; Anton Wellstein; En Yin Lai
Journal:  Hypertension       Date:  2020-10-12       Impact factor: 9.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.